Research & Development
Prometheus, Takeda launch prognostic tool for Crohn’s
LabPulse.com staff writers
According to Prometheus, CDPath is a personalized risk assessment tool that can be used in combination with a physician's clinical assessment to evaluate an adult patient's risk for developing serious complications of CD such as bowel strictures, internal penetrating disease, or non-perianal surgery within three years.
September 14, 2022
Page 1 of 1